Autolus Therapeutics plc SEC filings AUTL
Autolus Therapeutics plc has 336 filings in SEC EDGAR's recent list, going back to Feb 9, 2018. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 22, 2026 | — |
| 424B3 | Prospectus | Sep 22, 2026 | — |
| DEL AM | Filing | Sep 15, 2026 | — |
| S-3 | Shelf registration | Sep 14, 2026 | — |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 28, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 3, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Other events
|
Jun 9, 2026 | Jun 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| EFFECT | Filing | May 5, 2026 | — |
| EFFECT | Filing | May 5, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Apr 29, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Auditor change
|
Apr 16, 2026 | Apr 14, 2026 |
| UPLOAD | Letter from the SEC | Apr 15, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2026 | — |
| DEL AM | Filing | Apr 15, 2026 | — |
| DEL AM | Filing | Apr 15, 2026 | — |
| S-3 | Shelf registration | Apr 13, 2026 | — |
| S-3 | Shelf registration | Apr 13, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 8, 2026 | Apr 8, 2026 |
| 10-K | Annual report | Mar 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 27, 2026 | Mar 27, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 424B3 | Prospectus | Jan 26, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jan 26, 2026 | Jan 21, 2026 |
| 424B3 | Prospectus | Jan 12, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 3, 2025 | — |
| 424B3 | Prospectus | Dec 2, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 2, 2025 | Dec 1, 2025 |
| S-8 | Employee stock plan registration | Nov 18, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 424B3 | Prospectus | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 6, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2025 | Aug 12, 2025 |
| 424B3 | Prospectus | Jun 30, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2025 | Jun 26, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 25, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 424B3 | Prospectus | May 30, 2025 | — |
| 8-K |
Current report
Officer or director change
|
May 30, 2025 | May 23, 2025 |
| EFFECT | Filing | May 15, 2025 | — |
| 424B3 | Prospectus | May 15, 2025 | — |
| CORRESP | Letter to the SEC | May 13, 2025 | — |
| UPLOAD | Letter from the SEC | May 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| S-1 | Registration statement | May 8, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 7, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 23, 2025 | Apr 23, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 4, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2025 | Feb 28, 2025 |
| EFFECT | Filing | Mar 21, 2025 | — |
| POS AM | Filing | Mar 20, 2025 | — |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| POSASR | Filing | Mar 20, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| S-8 | Employee stock plan registration | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 12, 2024 | Nov 8, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 25, 2024 | — |
| CORRESP | Letter to the SEC | Sep 30, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 26, 2024 | Sep 26, 2024 |
| UPLOAD | Letter from the SEC | Sep 19, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 19, 2024 | Sep 13, 2024 |
| 144 | Notice of proposed sale | Sep 16, 2024 | — |
| 8-K |
Current report
Material agreement
|
Sep 13, 2024 | Sep 10, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 28, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Other events
|
Jun 5, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2024 | May 31, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | May 21, 2024 | — |
| 10-Q | Quarterly report | May 17, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 17, 2024 | May 17, 2024 |
| NT 10-Q | Filing | May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 1, 2024 | Mar 26, 2024 |
| S-3ASR | Automatic shelf registration | Mar 28, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 25, 2024 | — |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Restatement
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K/A |
Amended current report
Results of operations
|
Mar 15, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 14, 2024 | Mar 14, 2024 |
| D | Filing | Feb 23, 2024 | — |
| SC 13D | Ownership over 5% (active) | Feb 21, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 13, 2024 | Feb 13, 2024 |
| 424B5 | Prospectus supplement | Feb 9, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 8, 2024 | Feb 8, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 8, 2024 | Feb 6, 2024 |
| S-3ASR | Automatic shelf registration | Feb 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 31, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 26, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 10, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 22, 2023 | Dec 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 11, 2023 | Dec 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 27, 2023 | Nov 27, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 9, 2023 | Nov 9, 2023 |
| S-8 | Employee stock plan registration | Nov 3, 2023 | — |
| 6-K | Current report (foreign issuer) | Nov 2, 2023 | Sep 30, 2023 |
| S-8 | Employee stock plan registration | Aug 7, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 3, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jul 21, 2023 | Jul 21, 2023 |
| SC 13G | Ownership over 5% (passive) | Jul 10, 2023 | — |
| 6-K/A | Filing | Jul 7, 2023 | Jun 22, 2023 |
| 6-K | Current report (foreign issuer) | Jul 6, 2023 | Jul 3, 2023 |
| 6-K | Current report (foreign issuer) | Jun 20, 2023 | Jun 20, 2023 |
| 6-K | Current report (foreign issuer) | Jun 6, 2023 | Jun 6, 2023 |
| 6-K | Current report (foreign issuer) | Jun 6, 2023 | Jun 6, 2023 |
| 6-K | Current report (foreign issuer) | May 4, 2023 | Mar 31, 2023 |
| SC 13G | Ownership over 5% (passive) | Mar 20, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 14, 2023 | Mar 14, 2023 |
| 20-F | Annual report (foreign issuer) | Mar 7, 2023 | Dec 31, 2022 |
| F-6EF | Filing | Mar 1, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
| 6-K | Current report (foreign issuer) | Jan 23, 2023 | Jan 23, 2023 |
| 6-K | Current report (foreign issuer) | Dec 21, 2022 | Dec 21, 2022 |
| SC 13G | Ownership over 5% (passive) | Dec 19, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 13, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Dec 13, 2022 | — |
| 6-K | Current report (foreign issuer) | Dec 12, 2022 | Dec 9, 2022 |
| 424B5 | Prospectus supplement | Dec 12, 2022 | — |
| 6-K | Current report (foreign issuer) | Dec 8, 2022 | Dec 8, 2022 |
| 424B5 | Prospectus supplement | Dec 8, 2022 | — |
| 6-K/A | Filing | Nov 21, 2022 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 3, 2022 | Sep 30, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 5, 2022 | — |
| 6-K | Current report (foreign issuer) | Aug 4, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Jul 1, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Jun 1, 2022 | Jun 1, 2022 |
| 424B3 | Prospectus | May 18, 2022 | — |
| EFFECT | Filing | May 17, 2022 | — |
| CORRESP | Letter to the SEC | May 13, 2022 | — |
| UPLOAD | Letter from the SEC | May 9, 2022 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AUTL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- London, United Kingdom
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1730463
- Former names
- Autolus Therapeutics Ltd (until Jun 8, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.